Texte de la bannière

News and Events

Vibiosphen is proud to be part of a grooming ecosystem, we will be please to meet in these event

News

Microbiome Movement Drug Development Europe

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Microbiome Movement Drug Development Europe

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Human - Animal One Health: At the Confluence of human & veterinary public health

Integrating a One Health approach in the decision-making process is key for anticipating and tackling crises linked to emerging and reemerging pathogens that affect humans, animals or both

AMR Innovation Mission Sweden 2022

The Mission aims to connect the Swedish AMR ecosystem to the international AMR ecosystem and vice versa.

Webinar : les membres AFSSI ont la parole

At the AFSSI webinar on May 25, 2021 at 3 p.m., Patricia Martin, CSO, will present Vibiosphen's innovative solutions.

Anti infectives drug development Webinar 21-22 April 2021

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater ...

Virtual AMR Innovation Mission UK 2021

The AMR Innovation Mission UK 2021 aims to add to the global curbing of Antimicrobial resistance (AMR) ...